A platform for analyzing individual cell data and understanding complex tissues
Official title: A web-based platform for robust single-cell analysis, bulk data deconvolution and system-level analysis
Funded at Advaita Corporation · NIH-10915555 · Data updated 2026-11-12
This study is creating a new online tool to help scientists better understand individual cells and how they work, which could lead to new insights about different health conditions.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advaita Corporation NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $896,814 |
| NIH project number | 5R44GM152152-02 |
| Project ID | NIH-10915555 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with conditions that involve complex tissue compositions, such as cancer or autoimmune diseases.
✕Less likely to help
Patients with conditions that do not involve significant cellular complexity or those who are not undergoing treatment that requires detailed cellular analysis may not benefit from this research.
What this research studies
This research aims to develop a new web-based platform that enhances the analysis of single-cell data, which is crucial for understanding biological processes at a cellular level. By addressing the limitations of current computational methods, the platform will accurately identify different cell types, their developmental stages, and specific pathways involved in various conditions. It will also enable the deconvolution of bulk expression data, allowing researchers to extract valuable insights from existing datasets. This innovative approach could significantly improve how scientists interpret complex biological information.
Why it matters
Potential benefit: If successful, this research could lead to more precise diagnostics and targeted therapies by improving our understanding of cellular composition and function in diseases.
How similar studies have gone: Previous research has shown promise in single-cell analysis methodologies, indicating that this approach could build on existing successes in the field.
Where this research is happening
-
Advaita Corporation
Ann Arbor, United States Active
Researchers
- Principal investigator: Iosef, Cristiana — Advaita Corporation
- Study coordinator: Iosef, Cristiana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.